文献速递关节外科创伤骨科

急性血源性假体周围关节感染清创冲洗术后失败率升高

Increased Failure After Irrigation and Debridement for Acute Hematogenous Periprosthetic Joint Infection.
PubMed 文献 · J Bone Joint Surg Am · 2019-01-01

该回顾性单中心研究纳入2005至2016年199例因急性假体周围关节感染行清创冲洗术的全关节置换患者,急性血源性感染52例、术后急性感染147例。急性血源性感染1年失败率56%(29/52),高于术后急性感染的31%(46/147)(校正OR 2.36;95%CI 1.16至4.81;p=0.018)。

要点

  • 急性血源性假体周围关节感染清创冲洗术后1年失败率为56%(29/52),术后急性感染为31%(46/147)。
  • 既往翻修手术(校正OR 2.55)与较高Charlson合并症指数(校正OR 1.22)为失败宿主预测因素。
  • 混合微生物感染(校正OR 2.40)与慢性阻塞性肺疾病、糖尿病、恶性肿瘤病史及较高C反应蛋白水平与失败相关。

核心结论

  • 清创冲洗术用于急性血源性假体周围关节感染时失败率高,并识别出多项失败危险因素。
  • 研究结果可能有助于外科医生对急性假体周围关节感染患者的手术决策。

研究设计与样本

  • 回顾性单中心研究,纳入2005至2016年199例因急性术后假体周围关节感染(术后<3个月)或急性血源性假体周围关节感染(术后≥3个月且症状突然出现持续<3周)行清创冲洗术的全关节置换患者。
  • 仅纳入符合肌肉骨骼感染学会(MSIS)假体周围关节感染标准的患者。
  • 采用Delphi标准判定1年随访时的治疗失败,主要统计分析为单因素与多因素回归。
  • 证据等级为治疗性IV级。

主要发现

  • 1年总体失败率为37.7%(75/199)。
  • 急性血源性感染失败率为56%(29/52),术后急性感染为31%(46/147)(校正OR 2.36;95%CI 1.16至4.81;p=0.018)。
  • 失败宿主预测因素包括既往翻修手术(校正OR 2.55;95%CI 1.22至5.32;p=0.013)和较高Charlson合并症指数(校正OR 1.22;95%CI 1.01至1.51;p=0.048)。
  • 与失败相关的特定合并症包括慢性阻塞性肺疾病(p=0.026)、糖尿病(p=0.004)和恶性肿瘤病史(p=0.005)。
  • 混合微生物感染患者清创冲洗术后治疗失败可能性更高(校正OR 2.40;95%CI 1.10至5.20;p=0.028)。

关键数值与推荐

  • 假体周围关节感染诊断采用肌肉骨骼感染学会(MSIS)标准。
  • 治疗失败判定采用Delphi标准,评估1年随访结果。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute periprosthetic joint infection (PJI) is difficult to treat. In this study, we investigated the failure rates of irrigation and debridement (I&D) among patients with acute post-surgical and acute hematogenous PJI, and explored various host and organism-related risk factors that may be associated with treatment failure. METHODS: We retrospectively reviewed the cases of 199 total joint arthroplasty patients who underwent I&D for acute post-surgical PJI (<3 months postoperatively) and acute hematogenous PJI (≥3 months postoperatively, with abrupt symptoms lasting <3 weeks) at a single center during the period of 2005 to 2016. Only patients meeting the Musculoskeletal Infection Society (MSIS) criteria for PJI were included. Patient demographics, comorbidities, physical examination findings, laboratory results, and organism profile were identified. Treatment failure, as defined by the Delphi criteria, was determined for 1-year follow-up. Primary statistical analysis involved univariate and multivariate regression. RESULTS: The failure rate was 37.7% (75 of 199) at 1 year. Among the patients with acute hematogenous infections, the rate of failure (56%, 29 of 52) was almost 2 times higher than that of patients with acute post-surgical infections (31%, 46 of 147) (adjusted odds ratio [OR], 2.36; 95% confidence interval [CI], 1.16 to 4.81; p = 0.018). Host predictors of failure included prior revision surgery (adjusted OR, 2.55; 95% CI, 1.22 to 5.32; p = 0.013) and a higher Charlson Comorbidity Index (adjusted OR, 1.22; 95% CI, 1.01 to 1.51; p = 0.048). Specific comorbidities associated with failure included chronic obstructive pulmonary disease (p = 0.026), diabetes (p = 0.004), and a history of malignancy (p = 0.005). Patients with polymicrobial infections (adjusted OR, 2.40; 95% CI, 1.10 to 5.20; p = 0.028) were also more likely to experience failure of treatment after I&D. The clinical and laboratory risk factors associated with failure were the presence of intraoperative purulence (p = 0.05), elevated systolic blood pressure (p = 0.05), tachycardia (p = 0.06), and higher serum C-reactive protein level (p = 0.003). CONCLUSIONS: This study revealed that I&D is associated with a high rate of failure for patients with an acute hematogenous PJI. The study also identified a number of risk factors for failure. The findings of this study may allow better decision-making by surgeons regarding the surgical management of patients with acute PJI. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Shohat N, Goswami K, Tan TL, et al. Increased Failure After Irrigation and Debridement for Acute Hematogenous Periprosthetic Joint Infection. J Bone Joint Surg Am. 2019. PMID: 30994587. doi:10.2106/JBJS.18.00381

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。